Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-046629
Filing Date
2024-11-18
Accepted
2024-11-18 19:54:03
Documents
1
Period of Report
2024-11-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3163
  Complete submission text file 0001493152-24-046629.txt   4554
Mailing Address 750 ROYAL OAKS DR MONROVIA CA 91016
Business Address 750 ROYAL OAKS DR MONROVIA CA 91016 (626) - 415 - 1488
Invizyne Technologies Inc (Issuer) CIK: 0002010788 (see all company filings)

EIN.: 834550057 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 428 HAWTHORNE AVE APT 218 GLENDALE CA 91204
Business Address
Opgenorth Paul Hideo (Reporting) CIK: 0002033517 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42204 | Film No.: 241473039